EP3532499
AND-IL-33-MÓTEFNI OG NOTAGILDI ÞEIRRA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
24.10.2017EP published:
5.5.2021EP application number:
17794593.8
EP translation filed:
22.7.2021Grant published:
15.9.2021EPO information:
European Patent Register
Max expiry date:
23.10.2037Expiry date:
23.10.2026Next due date:
31.10.2026
Title:
ANTI-IL-33 ANTIBODIES AND USES THEREOF
Timeline
Today
24.10.2017EP application
5.5.2021EP Publication
22.7.2021Translation submitted
15.9.2021Registration published
23.10.2026Expires
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, Indianapolis, IN 46285, US
Inventor
Name:
BENSCHOP, Robert JanAddress:
Indianapolis, Indiana 46206-6288, US
Name:
DAVIES, JulianAddress:
Indianapolis, Indiana 46206-6288, US
Name:
OKRAGLY, Angela JeannineAddress:
Indianapolis, Indiana 46206-6288, US
Name:
PATEL, Chetankumar NatvarlalAddress:
Indianapolis, Indiana 46206-6288, US
Name:
TRUHLAR, Stephanie MarieAddress:
Indianapolis, IN 46206-6288, US
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201662414258 PDate:
28.10.2016Country:
US
Classification
Categories:
A61P 1/00, A61P 11/00, A61P 11/06, A61P 17/00, C07K 16/24, A61P 37/08
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 3.8.2021
Expires: 23.10.2022
Payer: Tego ehf.
Number: 6
Paid: 20.9.2022
Expires: 23.10.2023
Payer: Patice ehf.
Number: 7
Paid: 31.10.2023
Expires: 23.10.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 22.10.2024
Expires: 23.10.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 24.10.2025
Expires: 23.10.2026
Payer: Árnason Faktor ehf.